Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide…

You can get access to the report by clicking here now…

Joe Kiani Biography and Net Worth

Founder, CEO & Chairman of Masimo

Joe Kiani is the founder, chairman and CEO of Masimo Corporation, the medical technology company he founded in 1989.

Iranian-born, Kiani immigrated with his family to the United States when he was nine years old. Despite barely speaking English, Kiani graduated high school at the age of 15 and had earned both his bachelor’s and master’s degrees by the time he was 22.

In 1989, Kiani founded Masimo with the goal of improving patient care through pulse oximetry, one of the most widely-used monitoring technologies in hospitals worldwide. Masimo has consistently delivered noninvasive medical breakthroughs since its inception, including the invention of Pulse CO-Oximetry, Patient SafetyNet, and Rainbow Acoustic MonitoringTM.

Masimo is now publicly traded, and has grown to over 5,300 employees worldwide. Its pulse oximetry is used to monitor over 200 million patients per year, and is now used by 9 out of 10 hospitals listed in the 2019-2020 U.S. News & World Report “Best Hospitals Honor Roll.”

Kiani is the listed inventor on over 100 patents, and he has received numerous awards and honors for his contributions to the medical world. In 2011, Forbes named Masimo to its list of the “Top 20 Public Companies Under a Billion Dollars in Revenue,” and in 2005, Kiani was given San Diego State University College of Engineering's Monty Award. Kiani has served at the helm of six different companies, and currently serves on the board of eight.

Kiani received his undergraduate and graduate degrees from San Diego State University.

What is Joe E. Kiani's net worth?: The estimated net worth of Joe E. Kiani is at least $62.05 million as of May 25th, 2023. Mr. Kiani owns 366,055 shares of Masimo stock worth more than $62,053,644 as of December 22nd. This net worth approximation does not reflect any other investments that Mr. Kiani may own. Learn More about Joe E. Kiani's net worth.
How do I contact Joe E. Kiani?: The corporate mailing address for Mr. Kiani and other Masimo executives is 52 DISCOVERY, IRVINE CA, 92618. Masimo can also be reached via phone at (949) 297-7000 and via email at [email protected]. Learn More on Joe E. Kiani's contact information.
Has Joe E. Kiani been buying or selling shares of Masimo?: Joe E. Kiani has not been actively trading shares of Masimo during the past quarter. Most recently, on Thursday, May 25th, Joe E. Kiani bought 6,365 shares of Masimo stock. The stock was acquired at an average cost of $157.16 per share, with a total value of $1,000,323.40. Following the completion of the transaction, the chief executive officer now directly owns 366,055 shares of the company's stock, valued at $57,529,203.80. Learn More on Joe E. Kiani's trading history.
Who are Masimo's active insiders?: Masimo's insider roster includes H. Cohen (Director), Jon Coleman (Insider), Joe Kiani (Founder, CEO & Chairman), Tao Levy (EVP), Thomas McClenahan (EVP), Adam Mikkelson (Director), Bilal Muhsin (COO), Craig Reynolds (Director), Anand Sampath (EVP), and Micah Young (CFO). Learn More on Masimo's active insiders.
Are insiders buying or selling shares of Masimo?: During the last twelve months, insiders at the medical equipment provider sold shares 1 times. They sold a total of 40,000 shares worth more than $5,446,800.00. The most recent insider tranaction occured on April, 26th when Director Craig B Reynolds sold 40,000 shares worth more than $5,446,800.00. Insiders at Masimo own 9.7% of the company. Learn More about insider trades at Masimo.
Information on this page was last updated on 4/26/2024.

Joe E. Kiani Insider Trading History at Masimo

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/25/2023	Buy	6,365	$157.16	$1,000,323.40	366,055
12/15/2022	Buy	7,040	$144.79	$1,019,321.60	46,818
11/14/2022	Buy	31,994	$123.99	$3,966,936.06	39,778
11/11/2022	Buy	7,784	$129.27	$1,006,237.68	7,784
11/19/2021	Sell	8,416	$300.83	$2,531,785.28
11/17/2021	Sell	32,597	$300.54	$9,796,702.38
11/15/2021	Sell	27,599	$301.36	$8,317,234.64
11/12/2021	Sell	8,549	$300.03	$2,564,956.47
11/3/2021	Sell	200	$290.17	$58,034.00
11/1/2021	Sell	3,429	$290.08	$994,684.32
10/29/2021	Sell	18,967	$290.97	$5,518,827.99
10/26/2021	Sell	29,932	$291.13	$8,714,103.16
1/11/2021	Sell	9,034	$280.45	$2,533,585.30	179,241
1/7/2021	Sell	1,542	$280.05	$431,837.10	179,241
12/11/2020	Sell	6,038	$271.31	$1,638,169.78	195,867
12/8/2020	Sell	55,971	$270.68	$15,150,230.28	215,212
12/4/2020	Sell	11,688	$261.50	$3,056,412.00	247,553
10/27/2020	Sell	47,508	$250.47	$11,899,328.76	206,749
10/7/2020	Sell	52,492	$250.87	$13,168,668.04	211,733
4/22/2020	Sell	11,336	$200.27	$2,270,260.72	170,577
4/17/2020	Sell	111,468	$200.70	$22,371,627.60	270,709
4/15/2020	Sell	83,086	$199.58	$16,582,303.88	271,819
4/9/2020	Sell	51,942	$185.59	$9,639,915.78	177,265
4/6/2020	Sell	28,008	$185.31	$5,190,162.48	166,680
4/3/2020	Sell	36,155	$185.53	$6,707,837.15	166,680
3/13/2020	Sell	23,982	$185.76	$4,454,896.32	169,068
3/10/2020	Sell	50,569	$181.09	$9,157,540.21	209,810
8/1/2019	Sell	21,907	$160.01	$3,505,339.07	159,838
7/26/2019	Sell	18,437	$160.02	$2,950,288.74	157,678
7/1/2019	Sell	100,000	$150.14	$15,014,000.00	239,241
9/27/2018	Sell	2,467	$124.00	$305,908.00	175,399
9/25/2018	Sell	46,158	$124.04	$5,725,438.32	175,399
9/17/2018	Sell	200,555	$122.92	$24,652,220.60
9/4/2018	Sell	239,926	$117.95	$28,299,271.70	236,061
8/31/2018	Sell	126,927	$117.85	$14,958,346.95	236,061
8/6/2018	Sell	60,074	$109.05	$6,551,069.70	168,514
8/2/2018	Sell	29,273	$109.08	$3,193,098.84	168,514
5/1/2017	Sell	145,841	$102.37	$14,929,743.17	165,082
4/26/2017	Sell	154,159	$99.70	$15,369,652.30	219,241
4/25/2017	Sell	13,201	$101.00	$1,333,301.00	219,241
4/24/2017	Sell	100,000	$99.00	$9,900,000.00	219,241
2/16/2017	Sell	300,000	$80.04	$24,012,000.00	119,241
12/6/2016	Sell	52,859	$62.03	$3,278,843.77	119,241
12/1/2016	Sell	36,119	$62.06	$2,241,545.14	119,241
11/29/2016	Sell	104,870	$62.27	$6,530,254.90	119,241
11/23/2016	Sell	85,771	$62.06	$5,322,948.26	119,241
11/22/2016	Sell	869	$62.00	$53,878.00	119,241
11/21/2016	Sell	30,462	$62.04	$1,889,862.48	119,241
11/18/2016	Sell	20,381	$62.02	$1,264,029.62	119,241
10/10/2016	Sell	84,617	$60.26	$5,099,020.42	126,450
10/4/2016	Sell	4,300	$60.07	$258,301.00	121,441
10/3/2016	Sell	2,200	$60.00	$132,000.00	121,441
9/27/2016	Sell	4,464	$60.01	$267,884.64	123,705
9/22/2016	Sell	49,484	$60.18	$2,977,947.12	158,911
9/20/2016	Sell	400	$60.16	$24,064.00	120,240
9/19/2016	Sell	999	$60.03	$59,969.97	120,240
9/7/2016	Sell	33,536	$60.00	$2,012,160.00	152,777
6/7/2016	Sell	65,048	$50.00	$3,252,400.00	175,818
6/3/2016	Sell	234,952	$50.09	$11,768,745.68	313,797
7/21/2015	Sell	300,000	$40.55	$12,165,000.00

Joe E. Kiani Buying and Selling Activity at Masimo

Masimo Company Overview

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Today's Range

Now: $169.52

$166.97

$173.26

50 Day Range

MA: $160.45

$139.33

$177.70

2 Week Range

Now: $169.52

$101.61

$180.97

Volume

1,091,586 shs

Average Volume

664,998 shs

Market Capitalization

$9.08 billion

P/E Ratio

116.91

Dividend Yield

N/A

Beta

1.01

The #1 Coin for November 2024

From Crypto 101 Media | Ad